Cargando…
Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1
Induced pluripotent stem cells (iPSCs) were first established from differentiated somatic cells by gene introduction of key transcription factors, OCT4, SOX2, KLF4, and c-MYC, over a decade ago. Although iPSCs can be applicable for regenerative medicine, disease modeling and drug screening, several...
Autores principales: | Ishida, Tomoaki, Nakao, Shu, Ueyama, Tomoe, Harada, Yukihiro, Kawamura, Teruhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216665/ https://www.ncbi.nlm.nih.gov/pubmed/32426078 http://dx.doi.org/10.1186/s41232-020-00117-8 |
Ejemplares similares
-
c-Myc/microRNA-17-92 Axis Phase-Dependently Regulates PTEN and p21 Expression via ceRNA during Reprogramming to Mouse Pluripotent Stem Cells
por: Ishida, Tomoaki, et al.
Publicado: (2023) -
The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes
por: Ishida, Tomoaki, et al.
Publicado: (2021) -
STAT3 for Cardiac Regenerative Medicine: Involvement in Stem Cell Biology, Pathophysiology, and Bioengineering
por: Nakao, Shu, et al.
Publicado: (2020) -
Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases
por: Nakao, Shu, et al.
Publicado: (2020) -
Canonical Wnt signaling activation by chimeric antigen receptors for efficient cardiac differentiation from mouse embryonic stem cells
por: Sogo, Takahiro, et al.
Publicado: (2023)